Drugmaker AbbVie expects Humira volume erosion to worsen
Go back to Drugmaker AbbVie expects Humira volume erosion to worsen| AbbVie (NYSE: ABBV) | Delayed: 248.98 -1.11 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.09 | 52 Week High | $68.12 | |||
| Open | $246.45 | 52 Week Low | $50.71 | |||
| Day High | $249.08 | P/E | 54.01 | |||
| Day Low | $245.52 | EPS | $4.61 | |||
| Volume | 178,483 | |||||

